Epilepsy diagnosis is difficult: after a first seizure, 70–80% of electroencephalograms appear normal, leading to high misdiagnosis rates and delayed treatment. Current methods lack sensitivity and fail to detect subtle abnormalities. Patients with unclear diagnosis suffer from uncontrollable seizure, cannot drive and lose jobs, on top of facing psychological distress. Our solution is an AI-powered software that provides a new reading of the routine electroencephalograms to reveal hidden patterns invisible to the human eye. By enhancing diagnostic accuracy after a first seizure, it supports neurologists in making earlier, more reliable decisions. Seamlessly integrated into clinical workflows, it enables faster treatment initiation and better outcomes, without requiring new hardware.
19.08.2025
Venture Leaders Medtech 2025 kick-off their Boston roadshow (venturelab.swiss)
09.07.2025
Ten Medtech startups to explore US expansion opportunities (startupticker.ch)
08.07.2025
Venture Leaders Medtech 2025: Ten Swiss startups selected for US expansion (venturelab.swiss)
01.06.2025
Functional software developed
17.10.2024
Incoporation
15.09.2024
CHF 1.2M Pre-seed Round
No Jobs
No videos and documents
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Website:
www.deegtal.ai/
Headquarter:
Genève
Foundation Date:
October 2024
Technology:
Sectors: